Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin as a Neuroprotective Therapy for Glaucoma - A Randomized Controlled Trial

NCT05426044 is registered in ClinicalTrials.gov with Christopher Kai Shun Leung as lead sponsor.

NCT NCT05426044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05426044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin as a Neuroprotective Therapy for Glaucoma - A Randomized Controlled Trial
Lead sponsor
Christopher Kai Shun Leung
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2027
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma